3-methoxy-N-[2-(2,2,6,6-tetramethyl-4-phenyltetrahydropyran-4-yl)ethyl]aniline | 1313603-22-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 3-methoxy-N-[2-(2,2,6,6-tetramethyl-4-phenyltetrahydropyran-4-yl)ethyl]aniline
• 英文别名: Icmt-IN-1；3-methoxy-N-[2-(2,2,6,6-tetramethyl-4-phenyloxan-4-yl)ethyl]aniline
• CAS: 1313603-22-3
• 化学式: C₂₄H₃₃NO₂
• 分子量: 367.532
• InChiKey: AGLCGCXQQDBYKJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  30.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,2,6,6-四甲基-2H-3,5,6-三氢吡喃-4-酮 在 lithium aluminium tetrahydride 、 copper(I) bromide dimethylsulfide complex 、 ammonium acetate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 、 potassium hydroxide 、 bis(dibenzylideneacetone)-palladium⁽⁰⁾ 、 sodium t-butanolate 作用下， 以 四氢呋喃 、 乙醚 、 乙二醇 、 甲苯 为溶剂， 反应 3.5h， 生成 3-methoxy-N-[2-(2,2,6,6-tetramethyl-4-phenyltetrahydropyran-4-yl)ethyl]aniline
  参考文献：
  名称：

  Discovery and SAR of Methylated Tetrahydropyranyl Derivatives as Inhibitors of Isoprenylcysteine Carboxyl Methyltransferase (ICMT)

  摘要：

  A series of tetrahydropyranyl (THP) derivatives has been developed as potent inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT) for use as anticancer agents. Structural modification of the submicromolar hit compound 3 led to the potent 3-methoxy substituted analogue 27. Further SAR development around the THP ring resulted in an additional 10-fold increase in potency, exemplified by analogue 75 with an IC50 of 1.3 nM. Active and potent compounds demonstrated a dose-dependent increase in Ras cytosolic protein. Potent ICMT inhibitors also reduced cell viability in several cancer cell lines with growth inhibition (GI(50)) values ranging from 0.3 to >100 mu M. However, none of the cellular effects observed using ICMT inhibitors were as pronounced as those resulting from a farnesyltransferase inhibitor.

  DOI：

  10.1021/jm200249a

文献信息

• [EN] TETRAHYDROPYRAN-4-YLETHYLAMINO- OR TETRAHYDROPYRANYL-4-ETHYLOXY-PYRIMIDINES OR -PYRIDAZINES AS ISOPRENYLCYSTEINCARBOXYMETHYL TRANSFERASE INHIBITORS<br/>[FR] PYRIMIDINES OU PYRIDAZINES TÉTRAHYDROPYRAN-4-YLÉTHYLAMINO- OU TÉTRAHYDROPYRANYL-4-ÉTHYLOXY UTILES COMME INHIBITEURS DE L'ISOPRÉNYL-CYSTÉINE-CARBOXY-MÉTHYL-TRANSFÉRASE
  申请人：CANCER THERAPEUTICS CRC PTY LTD

  公开号：WO2014041349A1

  公开（公告）日：2014-03-20

  A compound of formula (I): wherein: R1 is selected from: (i) phenyl, optionally substituted by one fluoro group; (ii) thienyl; (iii) furanyl; (iv) C1-4 alkyl; and (v) H; R2 is selected from: (II), R3 is selected from: (III), X is selected from NH and O; R4 is selected from phenyl, a 5-membered heteroaryl or a 6-membered heteroaryl, all of which are optionally substituted by one or more substituents selected from the group consisting of: methyl, methoxy, trifluoromethyl, trifluoromethoxy, cyano, fluoro, -OC2H4OMe, and pyrazolyl.

  化合物的结构式（I）：其中：R1选自：（i）苯基，可选择一个氟原子取代；（ii）噻吩基；（iii）呋喃基；（iv）C1-4烷基；和（v）氢；R2选自：（II），R3选自：（III），X选自NH和O；R4选自苯基，5-成员杂环基或6-成员杂环基，均可选择一个或多个取代基，所述取代基选自：甲基，甲氧基，三氟甲基，三氟甲氧基，氰基，氟原子，-OC2H4OMe和吡唑基。
• [EN] ICMT Inhibitors<br/>[FR] INHIBITEURS D'ICMT
  申请人：UNIV SINGAPORE

  公开号：WO2013180656A1

  公开（公告）日：2013-12-05

  The invention provides a 1,3,5-substituted indole wherein the substituent at position 1 is a C6 to C12 alkyl group; the substituent at position 3 is CH2NR1R2 wherein R1 is H or C1 to C3 alkyl, R1 being optionally substituted with -OH, -SH, -NH2 or NHalkyl, wherein alkyl is a C1 to C4 alkyl group, and R2 is C1 to C3 alkyl or (CH2)n bonded to position 2 of the indole, wherein n is 1, 2 or 3; and the substituent at position 5 is either an optionally substituted nitrogen containing heteroaromatic ring or an aminosulfonylphenyl group or an alkylsulfonylphenyl group.

  该发明提供了一种1,3,5-取代吲哚，其中位置1处的取代基是C6到C12的烷基基团；位置3处的取代基是 NR1R2，其中R1是H或C1到C3的烷基，R1可选择地被-OH，-SH，-NH2或NH烷基取代，其中烷基是C1到C4的烷基基团，R2是C1到C3的烷基或(CH2)n与吲哚的位置2结合，其中n为1、2或3；位置5处的取代基是一个可选择地取代的含氮杂芳环或氨基磺基苯基团或烷基磺基苯基团。
• ICMT INHIBITORS
  申请人：National University of Singapore

  公开号：US20150218095A1

  公开（公告）日：2015-08-06

  The invention provides a 1,3,5-substituted indole wherein the substituent at position 1 is a C6 to C12 alkyl group; the substituent at position 3 is CH 2 NR 1 R 2 wherein R 1 is H or C1 to C3 alkyl, R 1 being optionally substituted with —OH, —SH, —NH 2 or NHalkyl, wherein alkyl is a C1 to C4 alkyl group, and R 2 is C1 to C3 alkyl or (CH 2 ) n bonded to position 2 of the indole, wherein n is 1, 2 or 3; and the substituent at position 5 is either an optionally substituted nitrogen containing heteroaromatic ring or an aminosulfonylphenyl group or an alkylsulfonylphenyl group.

  本发明提供了一种1,3,5-取代吲哚，其中第1位取代基为C6到C12烷基；第3位取代基为 NR1R2，其中R1为H或C1到C3烷基，R1可选地被取代为-OH，-SH，-NH2或NH烷基，其中烷基为C1到C4烷基，R2为C1到C3烷基或(CH2)n与吲哚的第2位连接，其中n为1、2或3；第5位取代基为可选取代的含氮杂芳环或氨基磺酰基苯基或烷基磺酰基苯基。
• US9422238B2
  申请人：——

  公开号：US9422238B2

  公开（公告）日：2016-08-23